Clinically, a positive correlation was detected between PDK4 immunoreactivity and advanced tumour stages, grades and serous histological subtypes, as well as metastasis, highlighting a potential role of PDK4 in ovarian cancer progression and aggressiveness. This evidence concerns the gene PDK4 and ovarian carcinoma.